These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8801361)

  • 1. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
    Kobayashi J; Itoh Y; Kitamura S; Kawai T
    Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
    Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
    J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
    Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
    J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].
    Harigai M
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1985-9. PubMed ID: 14621589
    [No Abstract]   [Full Text] [Related]  

  • 10. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
    J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
    Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
    Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
    Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
    J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis.
    Yokoyama A; Kondo K; Nakajima M; Matsushima T; Takahashi T; Nishimura M; Bando M; Sugiyama Y; Totani Y; Ishizaki T; Ichiyasu H; Suga M; Hamada H; Kohno N
    Respirology; 2006 Mar; 11(2):164-8. PubMed ID: 16548901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [KL-6 antigen].
    Kitamura S
    Nihon Rinsho; 1999 Dec; 57 Suppl():772-5. PubMed ID: 10778237
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
    Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
    Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease.
    Suzuki K; Takada H; Oka S; Kanouzawa S; Iimuro M; Kitazumi Y; Arima T; Ohyama R; Kuwayama H
    Intern Med; 2003 Aug; 42(8):650-4. PubMed ID: 12924486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone].
    Endoh Y; Hanai R; Uto K; Uno M; Nagashima H; Takizawa T; Narimatsu A; Ohnishi S; Kasanuki H
    J Cardiol; 2000 Feb; 35(2):121-7. PubMed ID: 10713933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia.
    Tanaka M; Tanaka K; Fukahori S; Fujimatsu Y; Jojima H; Shiraishi K; Honda J; Oizumi K
    Hematology; 2002 Apr; 7(2):105-8. PubMed ID: 12186700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.